Menu
×
West Ashley Library
Closed
Phone: (843) 766-6635
Folly Beach Library
Closed
Phone: (843) 588-2001
Edgar Allan Poe/Sullivan's Island Library
Closed for renovations
Phone: (843) 883-3914
Wando Mount Pleasant Library
Closed
Phone: (843) 805-6888
Village Library
Closed
Phone: (843) 884-9741
St. Paul's/Hollywood Library
Closed
Phone: (843) 889-3300
Otranto Road Library
Closed
Phone: (843) 572-4094
Mt. Pleasant Library
Closed
Phone: (843) 849-6161
McClellanville Library
Closed
Phone: (843) 887-3699
Keith Summey North Charleston Library
Closed
Phone: (843) 744-2489
John's Island Library
Closed
Phone: (843) 559-1945
Hurd/St. Andrews Library
Closed
Phone: (843) 766-2546
Miss Jane's Building (Edisto Library Temporary Location)
Closed
Phone: (843) 869-2355
Dorchester Road Library
Closed
Phone: (843) 552-6466
John L. Dart Library
Closed
Phone: (843) 722-7550
Baxter-Patrick James Island
Closed
Phone: (843) 795-6679
Main Library
2 p.m. – 5 p.m.
Phone: (843) 805-6930
Bees Ferry West Ashley Library
Closed
Phone: (843) 805-6892
Mobile Library
Closed
Phone: (843) 805-6909
Today's Hours
West Ashley Library
Closed
Phone: (843) 766-6635
Folly Beach Library
Closed
Phone: (843) 588-2001
Edgar Allan Poe/Sullivan's Island Library
Closed for renovations
Phone: (843) 883-3914
Wando Mount Pleasant Library
Closed
Phone: (843) 805-6888
Village Library
Closed
Phone: (843) 884-9741
St. Paul's/Hollywood Library
Closed
Phone: (843) 889-3300
Otranto Road Library
Closed
Phone: (843) 572-4094
Mt. Pleasant Library
Closed
Phone: (843) 849-6161
McClellanville Library
Closed
Phone: (843) 887-3699
Keith Summey North Charleston Library
Closed
Phone: (843) 744-2489
John's Island Library
Closed
Phone: (843) 559-1945
Hurd/St. Andrews Library
Closed
Phone: (843) 766-2546
Miss Jane's Building (Edisto Library Temporary Location)
Closed
Phone: (843) 869-2355
Dorchester Road Library
Closed
Phone: (843) 552-6466
John L. Dart Library
Closed
Phone: (843) 722-7550
Baxter-Patrick James Island
Closed
Phone: (843) 795-6679
Main Library
2 p.m. – 5 p.m.
Phone: (843) 805-6930
Bees Ferry West Ashley Library
Closed
Phone: (843) 805-6892
Mobile Library
Closed
Phone: (843) 805-6909
Patron Login
menu
Item request has been placed!
×
Item request cannot be made.
×
![loading](/sites/all/modules/hf_eds/images/loading.gif)
Ginsenoside Rg1 Prevents Chemotherapy-Induced Cognitive Impairment: Associations with Microglia-Mediated Cytokines, Neuroinflammation, and Neuroplasticity.
Item request has been placed!
×
Item request cannot be made.
×
![loading](/sites/all/modules/hf_eds/images/loading.gif)
- Author(s): Shi DD;Shi DD; Huang YH; Huang YH; Lai CSW; Lai CSW; Dong CM; Dong CM; Ho LC; Ho LC; Li XY; Li XY; Wu EX; Wu EX; Li Q; Li Q; Wang XM; Wang XM; Chen YJ; Chen YJ; Chung SK; Chung SK; Zhang ZJ; Zhang ZJ
- Source:
Molecular neurobiology [Mol Neurobiol] 2019 Aug; Vol. 56 (8), pp. 5626-5642. Date of Electronic Publication: 2019 Jan 18.- Publication Type:
Journal Article- Language:
English - Source:
- Additional Information
- Source: Publisher: Humana Press Country of Publication: United States NLM ID: 8900963 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1559-1182 (Electronic) Linking ISSN: 08937648 NLM ISO Abbreviation: Mol Neurobiol Subsets: MEDLINE
- Publication Information: Original Publication: Clifton, NJ : Humana Press, c1987-
- Subject Terms: Neuronal Plasticity*/drug effects; Antineoplastic Agents/*adverse effects ; Brain/*pathology ; Cognitive Dysfunction/*prevention & control ; Cytokines/*metabolism ; Ginsenosides/*therapeutic use ; Inflammation/*drug therapy ; Microglia/*pathology; Animals ; Anxiety/complications ; Anxiety/physiopathology ; Behavior, Animal ; Biomarkers/blood ; Brain/drug effects ; Brain/physiopathology ; Cognition/drug effects ; Cognitive Dysfunction/chemically induced ; Cognitive Dysfunction/drug therapy ; Cognitive Dysfunction/physiopathology ; Cytokines/blood ; Dendritic Spines/drug effects ; Dendritic Spines/pathology ; Female ; Ginsenosides/pharmacology ; Glial Fibrillary Acidic Protein/metabolism ; Inflammation/blood ; Inflammation/complications ; Inflammation/pathology ; Locomotion/drug effects ; Magnetic Resonance Imaging ; Mice, Inbred C57BL ; Mice, Transgenic ; Microglia/drug effects ; PC12 Cells ; Rats
- Abstract: Chemotherapy-induced cognitive impairment, also known as "chemobrain," is a common side effect. The purpose of this study was to examine whether ginsenoside Rg1, a ginseng-derived compound, could prevent chemobrain and its underlying mechanisms. A mouse model of chemobrain was developed with three injections of docetaxel, adriamycin, and cyclophosphamide (DAC) in combination at a 2-day interval. Rg1 (5 and 10 mg/kg daily) was given 1 week prior to DAC regimen for 3 weeks. An amount of 10 mg/kg Rg1 significantly improved chemobrain-like behavior in water maze test. In vivo neuroimaging revealed that Rg1 co-treatment reversed DAC-induced decreases in prefrontal and hippocampal neuronal activity and ameliorated cortical neuronal dendritic spine elimination. It normalized DAC-caused abnormalities in the expression of multiple neuroplasticity biomarkers in the two brain regions. Rg1 suppressed DAC-induced elevation of the proinflammatory cytokines tumor necrosis factor-α (TNF-α) and interleukin-6 (IL-6), but increased levels of the anti-inflammatory cytokines IL-4 and IL-10 in multiple sera and brain tissues. Rg1 also modulated cytokine mediators and inhibited DAC-induced microglial polarization from M2 to M1 phenotypes. In in vitro experiments, while impaired viability of PC12 neuroblastic cells and hyperactivation of BV-2 microglial cells, a model of neuroinflammation, were observed in the presence of DAC, Rg1 co-treatment strikingly reduced DAC's neurotoxic effects and neuroinflammatory response. These results indicate that Rg1 exerts its anti-chemobrain effect in an association with the inhibition of neuroinflammation by modulating microglia-mediated cytokines and the related upstream mediators, protecting neuronal activity and promoting neuroplasticity in particular brain regions associated with cognition processing.
- References: J Immunol. 2000 Feb 1;164(3):1364-71. (PMID: 10640751)
J Neurosci Res. 2001 Mar 15;63(6):509-15. (PMID: 11241586)
Acta Pharmacol Sin. 2001 Jul;22(7):657-62. (PMID: 11749833)
J Neuroinflammation. 2004 Jul 30;1(1):14. (PMID: 15285801)
Altern Med Rev. 2004 Sep;9(3):259-74. (PMID: 15387718)
Am J Epidemiol. 2006 Apr 1;163(7):645-53. (PMID: 16484447)
Neurobiol Dis. 2006 Jul;23(1):127-39. (PMID: 16697651)
J Neurochem. 2007 Jul;102(1):1-12. (PMID: 17394533)
J Psychopharmacol. 2009 Jan;23(1):74-83. (PMID: 18308784)
Breast Cancer Res Treat. 2009 Apr;114(3):579-87. (PMID: 18443903)
Neuroscience. 2008 Jul 17;154(4):1517-24. (PMID: 18554813)
J Alzheimers Dis. 2010;19(3):977-89. (PMID: 20157253)
Phytother Res. 2010 Dec;24(12):1748-54. (PMID: 20564503)
Mutat Res. 2010 Aug 7;690(1-2):57-63. (PMID: 20973164)
Biochim Biophys Acta. 2012 Feb;1822(2):286-92. (PMID: 22015470)
J Clin Oncol. 2012 Jan 20;30(3):274-81. (PMID: 22184379)
Br J Pharmacol. 2012 Jul;166(6):1872-87. (PMID: 22335772)
Nature. 2012 Feb 19;483(7387):87-91. (PMID: 22343895)
Curr Neurol Neurosci Rep. 2012 Jun;12(3):267-75. (PMID: 22453825)
Neuroscience. 2013 Oct 22;251:129-40. (PMID: 22522468)
J Neuroinflammation. 2012 May 31;9:115. (PMID: 22651808)
Neuroscience. 2012 Sep 18;220:191-200. (PMID: 22728092)
Brain Behav Immun. 2013 Mar;30 Suppl:S99-108. (PMID: 22884417)
PLoS One. 2013;8(3):e59155. (PMID: 23520555)
Eur J Pharmacol. 2013 Jun 15;710(1-3):29-38. (PMID: 23588117)
Neurosci Biobehav Rev. 2013 Sep;37(8):1311-21. (PMID: 23660455)
J Gerontol A Biol Sci Med Sci. 2014 Mar;69(3):282-94. (PMID: 23833204)
Evid Based Complement Alternat Med. 2014;2014:168940. (PMID: 24876866)
PLoS One. 2014 Jun 30;9(6):e101291. (PMID: 24979747)
Neural Regen Res. 2013 Jun 15;8(17):1606-14. (PMID: 25206457)
Cytokine. 2015 Mar;72(1):86-96. (PMID: 25573802)
Neuroscience. 2015 Apr 30;292:81-9. (PMID: 25724866)
Ann Oncol. 2015 Jul;26(7):1446-51. (PMID: 25922060)
Int J Clin Exp Pathol. 2015 Mar 01;8(3):2484-94. (PMID: 26045754)
Prog Neurobiol. 2015 Aug;131:65-86. (PMID: 26067058)
J Ethnopharmacol. 2015 Sep 15;173:231-40. (PMID: 26196399)
Neurosci Lett. 2015 Sep 25;605:24-8. (PMID: 26277823)
J Steroid Biochem Mol Biol. 2016 Jan;155(Pt A):94-103. (PMID: 26455404)
Toxicol Lett. 2016 Jan 22;243:7-21. (PMID: 26723869)
J Ginseng Res. 2015 Oct;39(4):384-91. (PMID: 26869832)
J Basic Clin Pharm. 2016 Mar;7(2):27-31. (PMID: 27057123)
Mol Med Rep. 2016 Jun;13(6):4904-10. (PMID: 27082952)
J Asian Nat Prod Res. 2016 Jun;18(6):587-95. (PMID: 27324597)
Neuropharmacology. 2017 Jan;112(Pt A):94-103. (PMID: 27425202)
Curr Neurol Neurosci Rep. 2016 Sep;16(9):81. (PMID: 27443648)
PLoS One. 2016 Oct 4;11(10):e0164204. (PMID: 27701469)
J Neuroimmunol. 2016 Oct 15;299:35-44. (PMID: 27725119)
Neurochem Res. 2017 May;42(5):1299-1307. (PMID: 28078612)
Intravital. 2015 Jan 6;3(3):e944439. (PMID: 28243511)
J Ethnopharmacol. 2017 Jul 12;206:178-183. (PMID: 28427912)
Biomed Pharmacother. 2017 Aug;92:962-971. (PMID: 28618657)
Evid Based Complement Alternat Med. 2017;2017:7842082. (PMID: 28656054)
Brain Sci. 2017 Jul 12;7(7):null. (PMID: 28704928)
Breast Cancer Res Treat. 2017 Nov;166(1):15-28. (PMID: 28707202)
J Neuroinflammation. 2017 Sep 8;14(1):183. (PMID: 28886715)
BMC Neurosci. 2017 Sep 25;18(1):69. (PMID: 28946859)
Neurobiol Dis. 2018 Jun;114:164-173. (PMID: 29534932) - Grant Information: 17115017 General Research Fund
- Contributed Indexing: Keywords: Chemobrain; Cytokines; Ginsenoside Rg1; In vivo neuroimaging; Neuroinflammation; Neuroplasticity
- Accession Number: 0 (Antineoplastic Agents)
0 (Biomarkers)
0 (Cytokines)
0 (Ginsenosides)
0 (Glial Fibrillary Acidic Protein)
PJ788634QY (ginsenoside Rg1) - Publication Date: Date Created: 20190120 Date Completed: 20191217 Latest Revision: 20200225
- Publication Date: 20231215
- Accession Number: 10.1007/s12035-019-1474-9
- Accession Number: 30659419
- Source:
Contact CCPL
Copyright 2022 Charleston County Public Library Powered By EBSCO Stacks 3.3.0 [350.3] | Staff Login
No Comments.